JAK2 V617F mutations and thrombosis in BCR-ABL1 negative myeloproliferative neoplasms: clinical profile and hematologic insights.

Leuk Res Rep · 2026 · PMC13126274 · PMID 42064391

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

reported higher WBC counts in JAK2-mutated PMF patients, a trend we observed in our study as well, although it did not reach statistical significance [ 27 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.